
|Articles|March 1, 2007
FDA grants orphan status to two Lux products
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.